Catino, A.; Lacalamita, R.; De Summa, S.; Pesola, F.; Tommasi, S.; Galetta, D.
Multiple Genetic Alterations as Resistance Mechanism during Second-Line Lorlatinib for Advanced ALK-Rearranged Lung Adenocarcinoma: A Case Report. Diagnostics 2022, 12, 682.
https://doi.org/10.3390/diagnostics12030682
AMA Style
Catino A, Lacalamita R, De Summa S, Pesola F, Tommasi S, Galetta D.
Multiple Genetic Alterations as Resistance Mechanism during Second-Line Lorlatinib for Advanced ALK-Rearranged Lung Adenocarcinoma: A Case Report. Diagnostics. 2022; 12(3):682.
https://doi.org/10.3390/diagnostics12030682
Chicago/Turabian Style
Catino, Annamaria, Rosanna Lacalamita, Simona De Summa, Francesco Pesola, Stefania Tommasi, and Domenico Galetta.
2022. "Multiple Genetic Alterations as Resistance Mechanism during Second-Line Lorlatinib for Advanced ALK-Rearranged Lung Adenocarcinoma: A Case Report" Diagnostics 12, no. 3: 682.
https://doi.org/10.3390/diagnostics12030682
APA Style
Catino, A., Lacalamita, R., De Summa, S., Pesola, F., Tommasi, S., & Galetta, D.
(2022). Multiple Genetic Alterations as Resistance Mechanism during Second-Line Lorlatinib for Advanced ALK-Rearranged Lung Adenocarcinoma: A Case Report. Diagnostics, 12(3), 682.
https://doi.org/10.3390/diagnostics12030682
